Last week Mark van den Boogaard (senior researcher at department of Intensive Care Medicine) received the Dr. Peter Moleman penning for best article in the field of psycho-pharmacy published in the last 2 years.For his article titled: Effect of Haloperidol on Survival among Critically ill Adults with a High Risk of Delirium: The REDUCE Randomized Clinical Trial published in JAMA this year. This multicenter study, including 1,789 ICU patients, showed that prophylatic use of haloperidol in critically ill patients with a high risk of delirium is not effective on all 16 measured outcomes.
See Psyfar blog (in Dutch) here.
Mark van den Boogaard is member of theme Healthcare improvement science.
Related news items
Radboud-led collaboration generates innovative candidate drug against malaria19 September 2019
A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.read more
Radboud university medical center opens first healthcare AI labs19 September 2019
These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.read more
Careful prescription of addictive painkillers still necessary19 September 2019
Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.read more
Exercising at home has a positive effect on Parkinson's patients19 September 2019
In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.read more